Vaxil Bio Ltd V.VXL

Alternate Symbol(s): VXLLF

Healthcare Biotechnology

Vaxil Bio Ltd. is a Canada-based biotechnology company. The Company is focused on a drug discovery and development platform based on Signal Peptides (SPs) which the Company deploys to fight infectious diseases and cancer. The Company’s most advanced product, ImMucin, a MUC1 SP-derived vaccine, completed a Phase I/II clinical trial in multiple myeloma. The Company also has a SP-based COVID-19 vaccine candidate and a SP-based tuberculosis vaccine / treatment candidate. In addition, The Company has mAb candidates for the treatment of oncology and infectious diseases to be used alone, and in combination with other treatments. It has also initiated a pre-clinical program for a drug delivery polymer that targets high affinity E-selectin (P-Esbp), which the Company licensed for development and commercialization from BGN Technologies. It exploits the properties of SP domains on crucial proteins to develop targeted therapies against cancer targets and infectious disease pathogens.

TSXV:VXL - Post by User

Vaxil Bio Ltd > Make no mistake about it

<< Previous

Bullboard Posts

Next >>

Comment by CamaroZL1on Feb 12, 2021 6:11pm

45 Views

Post# 32559389

RE:RE:RE:RE:Make no mistake about it

Im a big fan of the market knows. Would have been red as i said below 39. That would have been slap in face if you needed it. Long and feeling good even though there is only one active bear here lol. Jlane doesn't really count though dumb as rocks.

<< Previous

Bullboard Posts

Next >>

Eminent acquires promising Nevada gold project